STABLE PROTEIN FORMULATIONS

STABLE PROTEIN FORMULATIONS

The present invention relates generally to stable formulations comprising CTLA4Ig molecules, including lyophilized, and liquid formulations for administration via various routes including, for example, routes such as intravenous (IV) and subcutaneous (SC) for treating immune system diseases and tole...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MANISHA M. DALI, RAJESH B. GANDHI, SUNITA BORSADIA, CHARLES E. DAHLHEIM, MANOJ NERURKAR, VIJAY H. NARINGREKAR
Format: Patent
Sprache:eng ; por
Schlagworte:
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator MANISHA M. DALI
RAJESH B. GANDHI
SUNITA BORSADIA
CHARLES E. DAHLHEIM
MANOJ NERURKAR
VIJAY H. NARINGREKAR
description The present invention relates generally to stable formulations comprising CTLA4Ig molecules, including lyophilized, and liquid formulations for administration via various routes including, for example, routes such as intravenous (IV) and subcutaneous (SC) for treating immune system diseases and tolerance induction.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_PT1962886EE</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PT1962886EE</sourcerecordid><originalsourceid>FETCH-epo_espacenet_PT1962886EE3</originalsourceid><addsrcrecordid>eNrjZJAODnF08nFVCAjyD3H19FNw8w_yDfVxDPH09wvmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxASGGlmZGFhZmrq7GRCgBADR9IMc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>STABLE PROTEIN FORMULATIONS</title><source>esp@cenet</source><creator>MANISHA M. DALI ; RAJESH B. GANDHI ; SUNITA BORSADIA ; CHARLES E. DAHLHEIM ; MANOJ NERURKAR ; VIJAY H. NARINGREKAR</creator><creatorcontrib>MANISHA M. DALI ; RAJESH B. GANDHI ; SUNITA BORSADIA ; CHARLES E. DAHLHEIM ; MANOJ NERURKAR ; VIJAY H. NARINGREKAR</creatorcontrib><description>The present invention relates generally to stable formulations comprising CTLA4Ig molecules, including lyophilized, and liquid formulations for administration via various routes including, for example, routes such as intravenous (IV) and subcutaneous (SC) for treating immune system diseases and tolerance induction.</description><language>eng ; por</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20140107&amp;DB=EPODOC&amp;CC=PT&amp;NR=1962886E$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20140107&amp;DB=EPODOC&amp;CC=PT&amp;NR=1962886E$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MANISHA M. DALI</creatorcontrib><creatorcontrib>RAJESH B. GANDHI</creatorcontrib><creatorcontrib>SUNITA BORSADIA</creatorcontrib><creatorcontrib>CHARLES E. DAHLHEIM</creatorcontrib><creatorcontrib>MANOJ NERURKAR</creatorcontrib><creatorcontrib>VIJAY H. NARINGREKAR</creatorcontrib><title>STABLE PROTEIN FORMULATIONS</title><description>The present invention relates generally to stable formulations comprising CTLA4Ig molecules, including lyophilized, and liquid formulations for administration via various routes including, for example, routes such as intravenous (IV) and subcutaneous (SC) for treating immune system diseases and tolerance induction.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJAODnF08nFVCAjyD3H19FNw8w_yDfVxDPH09wvmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxASGGlmZGFhZmrq7GRCgBADR9IMc</recordid><startdate>20140107</startdate><enddate>20140107</enddate><creator>MANISHA M. DALI</creator><creator>RAJESH B. GANDHI</creator><creator>SUNITA BORSADIA</creator><creator>CHARLES E. DAHLHEIM</creator><creator>MANOJ NERURKAR</creator><creator>VIJAY H. NARINGREKAR</creator><scope>EVB</scope></search><sort><creationdate>20140107</creationdate><title>STABLE PROTEIN FORMULATIONS</title><author>MANISHA M. DALI ; RAJESH B. GANDHI ; SUNITA BORSADIA ; CHARLES E. DAHLHEIM ; MANOJ NERURKAR ; VIJAY H. NARINGREKAR</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_PT1962886EE3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; por</language><creationdate>2014</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>MANISHA M. DALI</creatorcontrib><creatorcontrib>RAJESH B. GANDHI</creatorcontrib><creatorcontrib>SUNITA BORSADIA</creatorcontrib><creatorcontrib>CHARLES E. DAHLHEIM</creatorcontrib><creatorcontrib>MANOJ NERURKAR</creatorcontrib><creatorcontrib>VIJAY H. NARINGREKAR</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MANISHA M. DALI</au><au>RAJESH B. GANDHI</au><au>SUNITA BORSADIA</au><au>CHARLES E. DAHLHEIM</au><au>MANOJ NERURKAR</au><au>VIJAY H. NARINGREKAR</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>STABLE PROTEIN FORMULATIONS</title><date>2014-01-07</date><risdate>2014</risdate><abstract>The present invention relates generally to stable formulations comprising CTLA4Ig molecules, including lyophilized, and liquid formulations for administration via various routes including, for example, routes such as intravenous (IV) and subcutaneous (SC) for treating immune system diseases and tolerance induction.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; por
recordid cdi_epo_espacenet_PT1962886EE
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title STABLE PROTEIN FORMULATIONS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T03%3A13%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MANISHA%20M.%20DALI&rft.date=2014-01-07&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EPT1962886EE%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true